ES2062521T3 - Peptidos sinteticos para una vacuna contra hiv-1. - Google Patents
Peptidos sinteticos para una vacuna contra hiv-1.Info
- Publication number
- ES2062521T3 ES2062521T3 ES90906803T ES90906803T ES2062521T3 ES 2062521 T3 ES2062521 T3 ES 2062521T3 ES 90906803 T ES90906803 T ES 90906803T ES 90906803 T ES90906803 T ES 90906803T ES 2062521 T3 ES2062521 T3 ES 2062521T3
- Authority
- ES
- Spain
- Prior art keywords
- against hiv
- synthetic peptides
- vaccine against
- hiv
- synthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229940126577 synthetic vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA INVENCION DESCRIBE LA IDENTIFICACION, CARACTERIZACION Y USO DE UN PEPTIDO SINTETICO, GPKEPFRDYVDRFYK(P24E), COMO PORTADOR DE CELULA-T PARA EL MONTAJE APROPIADO, CON EPITOPES DE CELULAS-B DEFINIDAS DE LA PROTEINA DE ENVUELTA DEL HIV-1, PARA LA CONSTRUCCION DE CANDIDATOS POTENCIALES A VACUNA SINTETICA, CONTRA HIV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898910145A GB8910145D0 (en) | 1989-05-03 | 1989-05-03 | Synthetic peptides for an hiv-1 vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2062521T3 true ES2062521T3 (es) | 1994-12-16 |
Family
ID=10656139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90906803T Expired - Lifetime ES2062521T3 (es) | 1989-05-03 | 1990-05-03 | Peptidos sinteticos para una vacuna contra hiv-1. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0470980B1 (es) |
JP (1) | JP2609764B2 (es) |
AT (1) | ATE102217T1 (es) |
CA (1) | CA2053921C (es) |
DE (1) | DE69007099T2 (es) |
DK (1) | DK0470980T3 (es) |
ES (1) | ES2062521T3 (es) |
GB (1) | GB8910145D0 (es) |
WO (1) | WO1990013564A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4039925A1 (de) * | 1990-12-14 | 1992-06-17 | Behringwerke Ag | Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung |
JPH0748276A (ja) * | 1992-03-26 | 1995-02-21 | Inmeru:Kk | Hiv感染症予防ワクチンおよびその製造法 |
GB9208218D0 (en) * | 1992-04-14 | 1992-05-27 | British Bio Technology | Hybrid particles |
CN1111540C (zh) * | 1993-06-09 | 2003-06-18 | 康诺特实验室有限公司 | 串联的合成hiv-1肽类 |
US5693325A (en) * | 1994-03-15 | 1997-12-02 | Molecumetics, Ltd. | Peptide vaccines and methods relating thereto |
FR2731225B1 (fr) * | 1995-03-03 | 2003-10-31 | Pasteur Institut | Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique |
EP1849869A3 (fr) | 1994-10-20 | 2011-05-18 | Institut Pasteur | Séquences nucléotidiques d'antigènes rétroviraux VIH-1 groupe (ou sous-groupe) 0 |
FR2734281B1 (fr) * | 1995-05-18 | 1997-07-25 | Commissariat Energie Atomique | Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1 |
US5972339A (en) * | 1997-11-13 | 1999-10-26 | The General Hospital Corporation | Method of eliciting anti-HIV-1 helper T cell responses |
US7105164B1 (en) | 1998-04-07 | 2006-09-12 | Sanofi Pasteur Limited | HIV-specific cytotoxic T-cell responses |
US6395714B1 (en) | 1999-02-24 | 2002-05-28 | Aventis Pasteur Limited | Expressing gp140 fragment of primary HIV-1 isolate |
AU2003290460A1 (en) * | 2003-12-24 | 2005-07-14 | Leiden University Medical Center | Synthetic protein as tumor-specific vaccine |
FR2882557A1 (fr) * | 2005-02-25 | 2006-09-01 | Centre Nat Rech Scient | Epitopes de vih et composition pharmaceutique les contenant |
GB0716494D0 (en) * | 2007-08-23 | 2007-10-03 | Isis Innovation | HIV-2 antigenic peptides |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0387914B1 (en) * | 1984-10-18 | 1993-08-04 | Institut Pasteur | Envelope antigens of the human immuno-deficiency virus, and their applications |
WO1986006414A1 (en) * | 1985-04-29 | 1986-11-06 | Genetic Systems Corporation | Synthetic antigens for the detection of aids-related disease |
EP0245362B1 (en) * | 1985-10-24 | 1994-06-29 | Ronald C. Kennedy | Synthetic peptides and use for diagnosis and vaccination for aids and arc |
JPH0762031B2 (ja) * | 1986-12-30 | 1995-07-05 | アメリカ合衆国 | エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド |
DE3850593T3 (de) * | 1987-03-25 | 2001-01-04 | Pasteur Institut | Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten. |
CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
-
1989
- 1989-05-03 GB GB898910145A patent/GB8910145D0/en active Pending
-
1990
- 1990-05-03 JP JP2507140A patent/JP2609764B2/ja not_active Expired - Lifetime
- 1990-05-03 CA CA002053921A patent/CA2053921C/en not_active Expired - Lifetime
- 1990-05-03 DK DK90906803.3T patent/DK0470980T3/da active
- 1990-05-03 DE DE69007099T patent/DE69007099T2/de not_active Expired - Lifetime
- 1990-05-03 AT AT90906803T patent/ATE102217T1/de not_active IP Right Cessation
- 1990-05-03 EP EP90906803A patent/EP0470980B1/en not_active Expired - Lifetime
- 1990-05-03 WO PCT/CA1990/000146 patent/WO1990013564A1/en active IP Right Grant
- 1990-05-03 ES ES90906803T patent/ES2062521T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0470980B1 (en) | 1994-03-02 |
GB8910145D0 (en) | 1989-06-21 |
CA2053921C (en) | 1999-07-20 |
DK0470980T3 (da) | 1994-03-28 |
ATE102217T1 (de) | 1994-03-15 |
JP2609764B2 (ja) | 1997-05-14 |
JPH04502013A (ja) | 1992-04-09 |
DE69007099T2 (de) | 1994-06-01 |
CA2053921A1 (en) | 1990-11-04 |
WO1990013564A1 (en) | 1990-11-15 |
EP0470980A1 (en) | 1992-02-19 |
DE69007099D1 (de) | 1994-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2062521T3 (es) | Peptidos sinteticos para una vacuna contra hiv-1. | |
PE20040554A1 (es) | Vacunas que comprenden proteinas de fusion | |
ES2053413T1 (es) | Peptidos que inducen anticuerpos que neutralizan aislados de vih-1 geneticamente divergentes. | |
PA8477801A1 (es) | (3s) tetrahidro-3-furanil (1s,2r)-3-[[4-aminofenil) sulfonil)] (isobutil) amino]-1-bencil-2-(fosfonooxi) propilcarbamato de calcio | |
ES2087737T3 (es) | Un derivado 5-o-desosaminil-eritronoluro a. | |
AR006689A1 (es) | Cartucho, caperuza y minipastilla como soporte de sustancia activa para aerosoles dosificadores libres de gas propelente | |
MX9204685A (es) | Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina. | |
AR011734A1 (es) | Analogos del peptido lh-rh, y composiciones farmaceuticas que los contienen | |
MX2021011997A (es) | Enlazadores de conjugacion mejorados. | |
ES2124922T3 (es) | Peptidos derivados de un retrovirus del grupo hiv y su uso. | |
ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
DE69836582D1 (de) | Kurze peptide die die aktivität serine/threonine kinasen modulieren | |
BR9813817A (pt) | Análogos de hemiasterlina | |
ES2090324T3 (es) | Vacuna anticoccidica recombinante. | |
ES2064324T3 (es) | Adn que codifica para un polipeptido con actividades anticoagulantes. | |
AR246310A1 (es) | Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante. | |
IT1249684B (it) | Epitopi della proteina env del virus dell'epatite c. | |
HUP9801572A2 (hu) | Chlamydia-vakcinák | |
CR5757A (es) | Nuevo marcador de seleccion | |
AU2381402A (en) | Small acid-soluble spore protein and uses thereof | |
CU23164A3 (es) | Proteina recombinante de union a aminas vasoactivas | |
ES2168253T3 (es) | Peptidos especificos para hcmv y su utilizacion. | |
ES2059305T3 (es) | Proteina del virus de la seudorrabia. | |
ES2095899T3 (es) | Peptidos de la proteina gag de vih, su preparacion y uso. | |
DE69122103D1 (de) | Antigerinnungspeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 470980 Country of ref document: ES |